Recently, Dong et al. 36 reported that the high presence of CD206+ TAMs in hepatocellular carcinoma markedly correlated with aggressive tumor phenotypes and were associated with poor prognosis. This evidence concerns the gene MRC1 and hepatocellular carcinoma.